Jinkui Yang
Capital Medical University
6 Papers
1 Citations
Jinkui Yang is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Effect of miR-21 on Renal Fibrosis by Regulating MMP-9 and TIMP1 in kk-ay Diabetic Nephropathy Mice
TL;DR: It is demonstrated that miR-21 contributes to renal fibrosis by mediating MMP9/TIMP1 and that inhibition of miR -21 may be a novel target for diabetic nephropathy.
144
Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy.
Sidong Li,Zhiguang Liu,Philip Joseph,Bo Hu,Lu Yin,Lap Ah Tse,Sumathy Rangarajan,Chuangshi Wang,Yang Wang,Shofiqul Islam,Weida Liu,Fanghong Lu,Yindong Li,Yan-ling Hou,Deren Qiang,Qian Zhao,Ning Li,Ren-Sheng Lei,Di Chen,Aiying Han,Guo Liang Liu,Peng Zhang,Ya-Hong Zhi,Chunmei Liu,Jinkui Yang,Aobulikasimu Resalaiti,Haibin Ma,Yuanting Ma,Yu Liu,Xiao-hui Xing,Quanyong Xiang,Zheng-Yi Liu,Yu Sheng,Jinghua Tang,Lisheng Liu,Salim Yusuf,Wei Li +36 more
TL;DR: Both CVD and mortality are higher in men compared with women, and in rural compared with urban areas, and large reductions could potentially be achieved by controlling metabolic risk factors and improving education.
93
Inhibition of STAT3 enhances UCP1 expression and mitochondrial function in brown adipocytes.
TL;DR: In this paper , Nifuroxazide (NFX) has been shown to have a pro-thermogenic effect on mature brown adipocytes, as evidenced by increased expression of thermogenic transcriptional factors and mitochondrial content.
5
15-LB: Safety and Efficacy of Tetramethylpyrazine Nitrone in Treating Patients with Type 2 Diabetes and Microalbuminuria—A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial
TL;DR: TBN is a promising new treatment for early DKD and its safety and efficacy will be further investigated in clinical trials.
2
A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes
Yingying Luo,Hongyuan Wang,Xianghai Zhou,Cuiqing Chang,Wei Chen,Xiaohui Guo,Jinkui Yang,Li Jin,Sanjoy K. Paul +8 more
TL;DR: For patients with prediabetes, neither intensive lifestyle intervention nor pioglitazone had led to a higher reversion rate to normal glucose state, and all the other three groups showed any significant benefit in terms of reverting back to normoglycemic state.